Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasite researchers win Nobel Prize
Mosquito
"This year’s Nobel Laureates have developed therapies that have revolutionised the treatment of some of the most devastating parasitic diseases” - Nobel assembly.
Awarded for work on malaria and roundworm therapies

The 2015 Nobel Prize in physiology or medicine has been awarded to three researchers for their contributions in developing novel therapies against malaria and roundworm parasite infection.

According to the Guardian, William Campbell and Satoshi Omura were awarded for their work on a therapy against roundworm, shared jointly with Tu Youyou, for a therapy against malaria.

In a statement published by Healio, the Nobel assembly said: "Diseases caused by parasites have plagued humankind for millennia and constitute a major global health problem. In particular, parasitic diseases affect the world’s poorest populations and represent a huge barrier to improving human health and well-being.

"This year’s Nobel Laureates have developed therapies that have revolutionised the treatment of some of the most devastating parasitic diseases.”

Tu discovered the life saving malaria ingredient by extracting the active ingredient of a traditional herbal medicine.

The component, later called artemisinin, targets the parasites during an early stage of their development. It is highly effective in both animals and humans, and is estimated to reduce the number of deaths caused by malaria by over 20 per cent.

Satoshi Omura's research explored the isolation and culture of several new strains of Streptomyces, which are known to have antibacterial qualities.

These were later acquired by William Campbell, who discovered that one of the cultures was effective against parasite infection in animals.  

This led to the discovery of avermectin and its derivative, Mectizan, which has contributed to the global fight against parasitic diseases such as river blindness and onchocerciasis.

Christopher Plowe, president of the American Society of Tropical Medicine and Hygiene, said:  “This year’s Prize recognises scientists who isolated compounds from bacteria and plants and developed them into drugs that have saved countless lives from malaria and prevented millions of cases of blindness and disfiguring swelling from parasitic worms worldwide.

“These three scientists have had a massive positive impact on global health. This was a great choice by the Nobel Committee.”

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.